nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—CYP1A2—Pentoxifylline—systemic scleroderma	0.139	0.193	CbGbCtD
Albendazole—CYP1A2—Leflunomide—systemic scleroderma	0.133	0.184	CbGbCtD
Albendazole—ABCB1—Lisinopril—systemic scleroderma	0.122	0.169	CbGbCtD
Albendazole—ABCB1—Captopril—systemic scleroderma	0.0911	0.127	CbGbCtD
Albendazole—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0717	0.0996	CbGbCtD
Albendazole—ABCB1—Prednisone—systemic scleroderma	0.0573	0.0796	CbGbCtD
Albendazole—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.043	0.0597	CbGbCtD
Albendazole—CYP3A4—Prednisone—systemic scleroderma	0.0343	0.0477	CbGbCtD
Albendazole—ABCB1—Methotrexate—systemic scleroderma	0.0288	0.04	CbGbCtD
Albendazole—Aplastic anaemia—Pentoxifylline—systemic scleroderma	0.0048	0.0189	CcSEcCtD
Albendazole—Intracranial pressure increased—Prednisone—systemic scleroderma	0.0039	0.0154	CcSEcCtD
Albendazole—Aplastic anaemia—Azathioprine—systemic scleroderma	0.00318	0.0125	CcSEcCtD
Albendazole—Renal failure acute—Captopril—systemic scleroderma	0.00305	0.012	CcSEcCtD
Albendazole—Pancytopenia—Pentoxifylline—systemic scleroderma	0.00305	0.012	CcSEcCtD
Albendazole—Hepatobiliary disease—Pentoxifylline—systemic scleroderma	0.00271	0.0107	CcSEcCtD
Albendazole—TUBA1A—connective tissue—systemic scleroderma	0.00263	0.0979	CbGeAlD
Albendazole—Hepatitis—Pentoxifylline—systemic scleroderma	0.00257	0.0101	CcSEcCtD
Albendazole—TUBA1A—smooth muscle tissue—systemic scleroderma	0.0024	0.0895	CbGeAlD
Albendazole—Renal failure acute—Mycophenolic acid—systemic scleroderma	0.0024	0.00945	CcSEcCtD
Albendazole—TUBA1A—skin of body—systemic scleroderma	0.00237	0.0884	CbGeAlD
Albendazole—Immune system disorder—Pentoxifylline—systemic scleroderma	0.00232	0.00915	CcSEcCtD
Albendazole—Pancytopenia—Captopril—systemic scleroderma	0.00231	0.00911	CcSEcCtD
Albendazole—Neutropenia—Captopril—systemic scleroderma	0.00227	0.00897	CcSEcCtD
Albendazole—Aplastic anaemia—Mycophenolate mofetil—systemic scleroderma	0.00226	0.0089	CcSEcCtD
Albendazole—Renal failure acute—Lisinopril—systemic scleroderma	0.00216	0.00851	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Captopril—systemic scleroderma	0.00215	0.00848	CcSEcCtD
Albendazole—Liver function test abnormal—Leflunomide—systemic scleroderma	0.00214	0.00844	CcSEcCtD
Albendazole—Liver function test abnormal—Mycophenolic acid—systemic scleroderma	0.00204	0.00805	CcSEcCtD
Albendazole—Agranulocytosis—Captopril—systemic scleroderma	0.00202	0.00798	CcSEcCtD
Albendazole—Pancytopenia—Azathioprine—systemic scleroderma	0.00202	0.00795	CcSEcCtD
Albendazole—Immune system disorder—Mometasone—systemic scleroderma	0.002	0.00789	CcSEcCtD
Albendazole—Leukopenia—Pentoxifylline—systemic scleroderma	0.002	0.00789	CcSEcCtD
Albendazole—Hepatitis—Captopril—systemic scleroderma	0.00195	0.00768	CcSEcCtD
Albendazole—Pancytopenia—Leflunomide—systemic scleroderma	0.0019	0.00751	CcSEcCtD
Albendazole—TUBA1A—digestive system—systemic scleroderma	0.0019	0.0707	CbGeAlD
Albendazole—Renal failure acute—Mycophenolate mofetil—systemic scleroderma	0.00189	0.00746	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—systemic scleroderma	0.00189	0.00745	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Azathioprine—systemic scleroderma	0.00188	0.0074	CcSEcCtD
Albendazole—Neutropenia—Leflunomide—systemic scleroderma	0.00187	0.00739	CcSEcCtD
Albendazole—Erythema multiforme—Captopril—systemic scleroderma	0.00184	0.00726	CcSEcCtD
Albendazole—Pancytopenia—Mycophenolic acid—systemic scleroderma	0.00182	0.00716	CcSEcCtD
Albendazole—TUBA1A—tendon—systemic scleroderma	0.0018	0.0673	CbGeAlD
Albendazole—Hepatobiliary disease—Azathioprine—systemic scleroderma	0.00179	0.00706	CcSEcCtD
Albendazole—Neutropenia—Mycophenolic acid—systemic scleroderma	0.00179	0.00705	CcSEcCtD
Albendazole—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00179	0.00705	CcSEcCtD
Albendazole—Skin disorder—Pentoxifylline—systemic scleroderma	0.00177	0.00699	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Leflunomide—systemic scleroderma	0.00177	0.00699	CcSEcCtD
Albendazole—Agranulocytosis—Azathioprine—systemic scleroderma	0.00177	0.00696	CcSEcCtD
Albendazole—TUBB4B—connective tissue—systemic scleroderma	0.00175	0.0652	CbGeAlD
Albendazole—Alopecia—Captopril—systemic scleroderma	0.00172	0.00678	CcSEcCtD
Albendazole—Hepatobiliary disease—Leflunomide—systemic scleroderma	0.00169	0.00666	CcSEcCtD
Albendazole—Agranulocytosis—Leflunomide—systemic scleroderma	0.00167	0.00658	CcSEcCtD
Albendazole—Pancytopenia—Lisinopril—systemic scleroderma	0.00164	0.00645	CcSEcCtD
Albendazole—Hepatobiliary disease—Mycophenolic acid—systemic scleroderma	0.00161	0.00636	CcSEcCtD
Albendazole—Liver function test abnormal—Mycophenolate mofetil—systemic scleroderma	0.00161	0.00636	CcSEcCtD
Albendazole—Neutropenia—Lisinopril—systemic scleroderma	0.00161	0.00635	CcSEcCtD
Albendazole—Erythema multiforme—Azathioprine—systemic scleroderma	0.00161	0.00633	CcSEcCtD
Albendazole—Hepatitis—Leflunomide—systemic scleroderma	0.0016	0.00633	CcSEcCtD
Albendazole—TUBB4B—smooth muscle tissue—systemic scleroderma	0.0016	0.0597	CbGeAlD
Albendazole—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00159	0.00627	CcSEcCtD
Albendazole—Urinary tract disorder—Leflunomide—systemic scleroderma	0.00158	0.00625	CcSEcCtD
Albendazole—TUBA1A—lung—systemic scleroderma	0.00158	0.059	CbGeAlD
Albendazole—TUBB4B—skin of body—systemic scleroderma	0.00158	0.0589	CbGeAlD
Albendazole—Urethral disorder—Leflunomide—systemic scleroderma	0.00157	0.0062	CcSEcCtD
Albendazole—Immune system disorder—Azathioprine—systemic scleroderma	0.00153	0.00605	CcSEcCtD
Albendazole—Hepatitis—Mycophenolic acid—systemic scleroderma	0.00153	0.00604	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.00152	0.006	CcSEcCtD
Albendazole—Erythema multiforme—Leflunomide—systemic scleroderma	0.00152	0.00598	CcSEcCtD
Albendazole—Urinary tract disorder—Mycophenolic acid—systemic scleroderma	0.00151	0.00596	CcSEcCtD
Albendazole—Alopecia—Azathioprine—systemic scleroderma	0.0015	0.00592	CcSEcCtD
Albendazole—Urethral disorder—Mycophenolic acid—systemic scleroderma	0.0015	0.00592	CcSEcCtD
Albendazole—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00149	0.00588	CcSEcCtD
Albendazole—Hepatobiliary disease—Lisinopril—systemic scleroderma	0.00145	0.00573	CcSEcCtD
Albendazole—Urticaria—Pentoxifylline—systemic scleroderma	0.00145	0.00572	CcSEcCtD
Albendazole—Immune system disorder—Leflunomide—systemic scleroderma	0.00145	0.00571	CcSEcCtD
Albendazole—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00144	0.00569	CcSEcCtD
Albendazole—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00144	0.00569	CcSEcCtD
Albendazole—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00565	CcSEcCtD
Albendazole—Agranulocytosis—Lisinopril—systemic scleroderma	0.00143	0.00565	CcSEcCtD
Albendazole—Alopecia—Leflunomide—systemic scleroderma	0.00142	0.00559	CcSEcCtD
Albendazole—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.00141	0.00556	CcSEcCtD
Albendazole—Hepatitis—Lisinopril—systemic scleroderma	0.00138	0.00544	CcSEcCtD
Albendazole—Urinary tract disorder—Lisinopril—systemic scleroderma	0.00136	0.00537	CcSEcCtD
Albendazole—Thrombocytopenia—Captopril—systemic scleroderma	0.00135	0.00534	CcSEcCtD
Albendazole—Alopecia—Mycophenolic acid—systemic scleroderma	0.00135	0.00533	CcSEcCtD
Albendazole—Urethral disorder—Lisinopril—systemic scleroderma	0.00135	0.00533	CcSEcCtD
Albendazole—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00134	0.0053	CcSEcCtD
Albendazole—Leukopenia—Azathioprine—systemic scleroderma	0.00132	0.00522	CcSEcCtD
Albendazole—Erythema multiforme—Lisinopril—systemic scleroderma	0.0013	0.00514	CcSEcCtD
Albendazole—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00129	0.00508	CcSEcCtD
Albendazole—Aplastic anaemia—Methotrexate—systemic scleroderma	0.00128	0.00504	CcSEcCtD
Albendazole—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00502	CcSEcCtD
Albendazole—TUBB4B—digestive system—systemic scleroderma	0.00126	0.0471	CbGeAlD
Albendazole—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00495	CcSEcCtD
Albendazole—Vertigo—Leflunomide—systemic scleroderma	0.00125	0.00495	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00125	0.00493	CcSEcCtD
Albendazole—Leukopenia—Leflunomide—systemic scleroderma	0.00125	0.00493	CcSEcCtD
Albendazole—Abdominal pain—Mometasone—systemic scleroderma	0.00124	0.00491	CcSEcCtD
Albendazole—Body temperature increased—Mometasone—systemic scleroderma	0.00124	0.00491	CcSEcCtD
Albendazole—Alopecia—Lisinopril—systemic scleroderma	0.00122	0.0048	CcSEcCtD
Albendazole—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00476	CcSEcCtD
Albendazole—Dizziness—Pentoxifylline—systemic scleroderma	0.00121	0.00476	CcSEcCtD
Albendazole—TUBB4B—tendon—systemic scleroderma	0.0012	0.0448	CbGeAlD
Albendazole—Vertigo—Mycophenolic acid—systemic scleroderma	0.0012	0.00472	CcSEcCtD
Albendazole—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.00119	0.0047	CcSEcCtD
Albendazole—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00119	0.0047	CcSEcCtD
Albendazole—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00467	CcSEcCtD
Albendazole—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00118	0.00466	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00118	0.00466	CcSEcCtD
Albendazole—Skin disorder—Azathioprine—systemic scleroderma	0.00117	0.00462	CcSEcCtD
Albendazole—Vomiting—Pentoxifylline—systemic scleroderma	0.00116	0.00458	CcSEcCtD
Albendazole—Rash—Pentoxifylline—systemic scleroderma	0.00115	0.00454	CcSEcCtD
Albendazole—Dermatitis—Pentoxifylline—systemic scleroderma	0.00115	0.00453	CcSEcCtD
Albendazole—Headache—Pentoxifylline—systemic scleroderma	0.00114	0.00451	CcSEcCtD
Albendazole—Gastrointestinal pain—Captopril—systemic scleroderma	0.00113	0.00446	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00113	0.00444	CcSEcCtD
Albendazole—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00112	0.0044	CcSEcCtD
Albendazole—Skin disorder—Leflunomide—systemic scleroderma	0.00111	0.00437	CcSEcCtD
Albendazole—Abdominal pain—Captopril—systemic scleroderma	0.00109	0.00431	CcSEcCtD
Albendazole—Body temperature increased—Captopril—systemic scleroderma	0.00109	0.00431	CcSEcCtD
Albendazole—Nausea—Pentoxifylline—systemic scleroderma	0.00108	0.00427	CcSEcCtD
Albendazole—Vertigo—Lisinopril—systemic scleroderma	0.00108	0.00425	CcSEcCtD
Albendazole—Leukopenia—Lisinopril—systemic scleroderma	0.00107	0.00424	CcSEcCtD
Albendazole—Renal failure acute—Methotrexate—systemic scleroderma	0.00107	0.00422	CcSEcCtD
Albendazole—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00421	CcSEcCtD
Albendazole—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00106	0.0042	CcSEcCtD
Albendazole—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00106	0.00416	CcSEcCtD
Albendazole—TUBB4B—lung—systemic scleroderma	0.00106	0.0394	CbGeAlD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00101	0.004	CcSEcCtD
Albendazole—Vomiting—Mometasone—systemic scleroderma	0.001	0.00395	CcSEcCtD
Albendazole—Rash—Mometasone—systemic scleroderma	0.000993	0.00391	CcSEcCtD
Albendazole—ABCB1—blood vessel—systemic scleroderma	0.000993	0.037	CbGeAlD
Albendazole—Dermatitis—Mometasone—systemic scleroderma	0.000992	0.00391	CcSEcCtD
Albendazole—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000987	0.00389	CcSEcCtD
Albendazole—Headache—Mometasone—systemic scleroderma	0.000986	0.00389	CcSEcCtD
Albendazole—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000959	0.00378	CcSEcCtD
Albendazole—Neutropenia—Prednisone—systemic scleroderma	0.000956	0.00377	CcSEcCtD
Albendazole—Body temperature increased—Azathioprine—systemic scleroderma	0.000954	0.00376	CcSEcCtD
Albendazole—Abdominal pain—Azathioprine—systemic scleroderma	0.000954	0.00376	CcSEcCtD
Albendazole—Skin disorder—Lisinopril—systemic scleroderma	0.000951	0.00375	CcSEcCtD
Albendazole—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000944	0.00373	CcSEcCtD
Albendazole—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000941	0.00371	CcSEcCtD
Albendazole—Nausea—Mometasone—systemic scleroderma	0.000935	0.00369	CcSEcCtD
Albendazole—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000932	0.00368	CcSEcCtD
Albendazole—Dizziness—Captopril—systemic scleroderma	0.000914	0.00361	CcSEcCtD
Albendazole—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000913	0.0036	CcSEcCtD
Albendazole—Urticaria—Leflunomide—systemic scleroderma	0.000905	0.00357	CcSEcCtD
Albendazole—Abdominal pain—Leflunomide—systemic scleroderma	0.000901	0.00355	CcSEcCtD
Albendazole—Body temperature increased—Leflunomide—systemic scleroderma	0.000901	0.00355	CcSEcCtD
Albendazole—Hypersensitivity—Azathioprine—systemic scleroderma	0.000889	0.00351	CcSEcCtD
Albendazole—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000889	0.00351	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000889	0.00351	CcSEcCtD
Albendazole—CYP1A1—skin of body—systemic scleroderma	0.000885	0.033	CbGeAlD
Albendazole—Vomiting—Captopril—systemic scleroderma	0.000879	0.00347	CcSEcCtD
Albendazole—Rash—Captopril—systemic scleroderma	0.000872	0.00344	CcSEcCtD
Albendazole—Dermatitis—Captopril—systemic scleroderma	0.000871	0.00344	CcSEcCtD
Albendazole—Headache—Captopril—systemic scleroderma	0.000866	0.00342	CcSEcCtD
Albendazole—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000859	0.00339	CcSEcCtD
Albendazole—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000859	0.00339	CcSEcCtD
Albendazole—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00084	0.00331	CcSEcCtD
Albendazole—Hypersensitivity—Leflunomide—systemic scleroderma	0.00084	0.00331	CcSEcCtD
Albendazole—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000833	0.00329	CcSEcCtD
Albendazole—Nausea—Captopril—systemic scleroderma	0.000821	0.00324	CcSEcCtD
Albendazole—Pancytopenia—Methotrexate—systemic scleroderma	0.000812	0.0032	CcSEcCtD
Albendazole—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000801	0.00316	CcSEcCtD
Albendazole—Neutropenia—Methotrexate—systemic scleroderma	0.000799	0.00315	CcSEcCtD
Albendazole—Dizziness—Azathioprine—systemic scleroderma	0.000798	0.00315	CcSEcCtD
Albendazole—Urticaria—Lisinopril—systemic scleroderma	0.000778	0.00307	CcSEcCtD
Albendazole—Abdominal pain—Lisinopril—systemic scleroderma	0.000774	0.00305	CcSEcCtD
Albendazole—Body temperature increased—Lisinopril—systemic scleroderma	0.000774	0.00305	CcSEcCtD
Albendazole—Vomiting—Azathioprine—systemic scleroderma	0.000767	0.00303	CcSEcCtD
Albendazole—Rash—Azathioprine—systemic scleroderma	0.000761	0.003	CcSEcCtD
Albendazole—Dermatitis—Azathioprine—systemic scleroderma	0.00076	0.003	CcSEcCtD
Albendazole—Headache—Azathioprine—systemic scleroderma	0.000756	0.00298	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000755	0.00298	CcSEcCtD
Albendazole—Dizziness—Leflunomide—systemic scleroderma	0.000754	0.00297	CcSEcCtD
Albendazole—Immune system disorder—Prednisone—systemic scleroderma	0.000739	0.00292	CcSEcCtD
Albendazole—Vomiting—Leflunomide—systemic scleroderma	0.000725	0.00286	CcSEcCtD
Albendazole—Alopecia—Prednisone—systemic scleroderma	0.000723	0.00285	CcSEcCtD
Albendazole—Hypersensitivity—Lisinopril—systemic scleroderma	0.000721	0.00285	CcSEcCtD
Albendazole—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000721	0.00284	CcSEcCtD
Albendazole—Dizziness—Mycophenolic acid—systemic scleroderma	0.000719	0.00284	CcSEcCtD
Albendazole—Rash—Leflunomide—systemic scleroderma	0.000719	0.00283	CcSEcCtD
Albendazole—Dermatitis—Leflunomide—systemic scleroderma	0.000718	0.00283	CcSEcCtD
Albendazole—CYP1A2—digestive system—systemic scleroderma	0.000717	0.0267	CbGeAlD
Albendazole—Nausea—Azathioprine—systemic scleroderma	0.000717	0.00283	CcSEcCtD
Albendazole—Headache—Leflunomide—systemic scleroderma	0.000714	0.00282	CcSEcCtD
Albendazole—Agranulocytosis—Methotrexate—systemic scleroderma	0.000711	0.0028	CcSEcCtD
Albendazole—CYP1A1—digestive system—systemic scleroderma	0.000708	0.0264	CbGeAlD
Albendazole—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000702	0.00277	CcSEcCtD
Albendazole—Vomiting—Mycophenolic acid—systemic scleroderma	0.000691	0.00273	CcSEcCtD
Albendazole—Rash—Mycophenolic acid—systemic scleroderma	0.000685	0.0027	CcSEcCtD
Albendazole—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000685	0.0027	CcSEcCtD
Albendazole—Hepatitis—Methotrexate—systemic scleroderma	0.000684	0.0027	CcSEcCtD
Albendazole—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000682	0.00269	CcSEcCtD
Albendazole—Headache—Mycophenolic acid—systemic scleroderma	0.000681	0.00269	CcSEcCtD
Albendazole—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000678	0.00267	CcSEcCtD
Albendazole—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000678	0.00267	CcSEcCtD
Albendazole—Nausea—Leflunomide—systemic scleroderma	0.000677	0.00267	CcSEcCtD
Albendazole—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000676	0.00266	CcSEcCtD
Albendazole—Urethral disorder—Methotrexate—systemic scleroderma	0.000671	0.00264	CcSEcCtD
Albendazole—Dizziness—Lisinopril—systemic scleroderma	0.000648	0.00255	CcSEcCtD
Albendazole—Erythema multiforme—Methotrexate—systemic scleroderma	0.000647	0.00255	CcSEcCtD
Albendazole—Nausea—Mycophenolic acid—systemic scleroderma	0.000646	0.00255	CcSEcCtD
Albendazole—Vertigo—Prednisone—systemic scleroderma	0.00064	0.00253	CcSEcCtD
Albendazole—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000632	0.00249	CcSEcCtD
Albendazole—Vomiting—Lisinopril—systemic scleroderma	0.000623	0.00246	CcSEcCtD
Albendazole—Immune system disorder—Methotrexate—systemic scleroderma	0.000618	0.00244	CcSEcCtD
Albendazole—Rash—Lisinopril—systemic scleroderma	0.000617	0.00244	CcSEcCtD
Albendazole—Dermatitis—Lisinopril—systemic scleroderma	0.000617	0.00243	CcSEcCtD
Albendazole—Headache—Lisinopril—systemic scleroderma	0.000613	0.00242	CcSEcCtD
Albendazole—Alopecia—Methotrexate—systemic scleroderma	0.000605	0.00238	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000602	0.00238	CcSEcCtD
Albendazole—CYP1A2—lung—systemic scleroderma	0.000599	0.0223	CbGeAlD
Albendazole—CYP1A1—lung—systemic scleroderma	0.000591	0.022	CbGeAlD
Albendazole—Nausea—Lisinopril—systemic scleroderma	0.000582	0.00229	CcSEcCtD
Albendazole—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000567	0.00224	CcSEcCtD
Albendazole—Skin disorder—Prednisone—systemic scleroderma	0.000565	0.00223	CcSEcCtD
Albendazole—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000545	0.00215	CcSEcCtD
Albendazole—Rash—Mycophenolate mofetil—systemic scleroderma	0.000541	0.00213	CcSEcCtD
Albendazole—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00054	0.00213	CcSEcCtD
Albendazole—Headache—Mycophenolate mofetil—systemic scleroderma	0.000537	0.00212	CcSEcCtD
Albendazole—Vertigo—Methotrexate—systemic scleroderma	0.000535	0.00211	CcSEcCtD
Albendazole—Leukopenia—Methotrexate—systemic scleroderma	0.000533	0.0021	CcSEcCtD
Albendazole—CYP3A4—digestive system—systemic scleroderma	0.000519	0.0194	CbGeAlD
Albendazole—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00051	0.00201	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000503	0.00199	CcSEcCtD
Albendazole—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000476	0.00188	CcSEcCtD
Albendazole—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000476	0.00188	CcSEcCtD
Albendazole—Skin disorder—Methotrexate—systemic scleroderma	0.000472	0.00186	CcSEcCtD
Albendazole—Urticaria—Prednisone—systemic scleroderma	0.000462	0.00182	CcSEcCtD
Albendazole—Body temperature increased—Prednisone—systemic scleroderma	0.00046	0.00181	CcSEcCtD
Albendazole—Abdominal pain—Prednisone—systemic scleroderma	0.00046	0.00181	CcSEcCtD
Albendazole—Hypersensitivity—Prednisone—systemic scleroderma	0.000428	0.00169	CcSEcCtD
Albendazole—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000397	0.00157	CcSEcCtD
Albendazole—Urticaria—Methotrexate—systemic scleroderma	0.000386	0.00152	CcSEcCtD
Albendazole—Dizziness—Prednisone—systemic scleroderma	0.000385	0.00152	CcSEcCtD
Albendazole—Abdominal pain—Methotrexate—systemic scleroderma	0.000384	0.00152	CcSEcCtD
Albendazole—Body temperature increased—Methotrexate—systemic scleroderma	0.000384	0.00152	CcSEcCtD
Albendazole—Vomiting—Prednisone—systemic scleroderma	0.00037	0.00146	CcSEcCtD
Albendazole—ABCB1—digestive system—systemic scleroderma	0.000368	0.0137	CbGeAlD
Albendazole—Rash—Prednisone—systemic scleroderma	0.000367	0.00145	CcSEcCtD
Albendazole—Dermatitis—Prednisone—systemic scleroderma	0.000366	0.00144	CcSEcCtD
Albendazole—Headache—Prednisone—systemic scleroderma	0.000364	0.00144	CcSEcCtD
Albendazole—Hypersensitivity—Methotrexate—systemic scleroderma	0.000358	0.00141	CcSEcCtD
Albendazole—Nausea—Prednisone—systemic scleroderma	0.000345	0.00136	CcSEcCtD
Albendazole—Dizziness—Methotrexate—systemic scleroderma	0.000321	0.00127	CcSEcCtD
Albendazole—Vomiting—Methotrexate—systemic scleroderma	0.000309	0.00122	CcSEcCtD
Albendazole—ABCB1—lung—systemic scleroderma	0.000307	0.0114	CbGeAlD
Albendazole—Rash—Methotrexate—systemic scleroderma	0.000306	0.00121	CcSEcCtD
Albendazole—Dermatitis—Methotrexate—systemic scleroderma	0.000306	0.00121	CcSEcCtD
Albendazole—Headache—Methotrexate—systemic scleroderma	0.000304	0.0012	CcSEcCtD
Albendazole—Nausea—Methotrexate—systemic scleroderma	0.000289	0.00114	CcSEcCtD
